Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles
NCT ID: NCT01795417
Last Updated: 2013-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2012-08-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
NCT03776461
Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles
NCT06441799
TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and Rhytides
NCT01859611
Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
NCT05096247
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
NCT05929625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
XP200 device RF treatments
Every subject in the study will undergo 4 treatments and will be followed up for 6 months with photoraphic 3 evaluations: before treatment, 3 and 6 months follow-up. Photographs will be scored on a Fitzpatrick scale by 3 blinded evaluators.
RF XP200
Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device
XP200 RF device
4 RF treatments of periorbital region on one side of the face
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RF XP200
Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device
XP200 RF device
4 RF treatments of periorbital region on one side of the face
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* periorbital wrinkles
35 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BTL Industries Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgi Petkov
Role: STUDY_DIRECTOR
BTL Industries Ltd.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XP200 3.25 MHZ RF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.